CNS earnings date and last-quarter result: next report 2026-10-15, last quarter miss, P/E 24.59. Updated 2026-07-23.
Cohen & Steers (CNS) Research Hub
Cohen & Steers (CNS) trades on NYSE, US in the Financial Services (Asset Management) sector. As of 2026-10-26, shares last closed at 71.14 USD (+0.20%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 24.59, market cap 4.10B. This hub links to the full technical, earnings and options research available for CNS.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Financial Services (Asset Management) |
|---|---|
| Exchange | NYSE, US |
| Last close | 71.14 USD (+0.20%) |
| 52-week range | 65.075 USD – 86.56 USD |
| Trend regime | Range |
| 14-day RSI | 46.4 (Neutral) |
| Trailing P/E | 24.59 |
| Market cap | 4.10B |
| Dividend yield | 3.21% |
| Next earnings | 2026-10-15 |
Available research for CNS
Covered Call on CNS: how it works, illustrative setup around the real 71.14 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on CNS: how it works, illustrative setup around the real 71.14 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on CNS: how it works, illustrative setup around the real 71.14 USD price, max profit/loss, breakeven and when to use it. Educational.
CNS technical analysis: range, last 71.14 USD, RSI 46.4, 52w range 65.075 USD–86.56 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is CNS in?
Cohen & Steers (CNS) is classified under Financial Services (Asset Management), listed on NYSE, US.
Is CNS in an uptrend or downtrend?
As of 2026-10-26, CNS is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is CNS's trailing P/E ratio?
CNS's trailing P/E is 24.59, with a market cap of 4.10B. See the earnings research page for full valuation detail.
When does CNS next report earnings?
CNS is next scheduled to report earnings on 2026-10-15.